Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H14Cl2FNO5 |
| Molecular Weight | 378.18 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](OCC3=CC=C(Cl)C(Cl)=C3)[C@@](N)(C(O)=O)[C@]1([H])[C@@]2(F)C(O)=O
InChI
InChIKey=LFAGGDAZZKUVKO-JAGWWQSPSA-N
InChI=1S/C15H14Cl2FNO5/c16-8-2-1-6(3-9(8)17)5-24-10-4-7-11(14(7,18)12(20)21)15(10,19)13(22)23/h1-3,7,10-11H,4-5,19H2,(H,20,21)(H,22,23)/t7-,10-,11+,14-,15+/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists. | 2004 Aug 26 |
|
| MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. | 2004 Mar |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MGS-0039
Created by
admin on Sat Dec 16 10:59:31 GMT 2023 , Edited by admin on Sat Dec 16 10:59:31 GMT 2023
|
PRIMARY | |||
|
9886034
Created by
admin on Sat Dec 16 10:59:31 GMT 2023 , Edited by admin on Sat Dec 16 10:59:31 GMT 2023
|
PRIMARY | |||
|
DTXSID40432407
Created by
admin on Sat Dec 16 10:59:31 GMT 2023 , Edited by admin on Sat Dec 16 10:59:31 GMT 2023
|
PRIMARY | |||
|
M8KC1PQ31A
Created by
admin on Sat Dec 16 10:59:31 GMT 2023 , Edited by admin on Sat Dec 16 10:59:31 GMT 2023
|
PRIMARY | |||
|
569686-87-9
Created by
admin on Sat Dec 16 10:59:31 GMT 2023 , Edited by admin on Sat Dec 16 10:59:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
